The development of mifépristone : A pharmaceutical drama in three acts, J Am Med Womens Assoc, vol.55, issue.3, pp.117-137, 2000. ,
The efficacy of medical abortion: a meta-analysis, Contraception, vol.61, issue.1, pp.29-40, 2000. ,
DOI : 10.1016/S0010-7824(99)00115-8
Mifépristone : ten years later. Contraception, pp.1-7, 2010. ,
Interruption volontaire de grossesse par méthode médicamenteuse, Déc, vol.Argumentaire, pp.1-58, 2010. ,
Les interruptions volontaires de grossesses en, 2012. ,
Les interruptions volontaires de grossesses en 2007, Etudes et résultats ,
Les établissements et professionnels réalisant des IVG. Etudes et résultats, Déc, vol.712, pp.1-6, 2009. ,
Comparison of gemeprost and vaginal misoprostol in first trimester mifepristone induced abortion. Contraception, pp.28-32, 2005. ,
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.. II: Side effects and women's perceptions, BJOG: An International Journal of Obstetrics and Gynaecology, vol.307, issue.7, pp.715-740, 2004. ,
DOI : 10.1016/S0010-7824(99)00119-5
Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial, BJOG: An International Journal of Obstetrics & Gynaecology, vol.19, issue.10 ,
DOI : 10.1111/j.1471-0528.2010.02636.x
Etude aMaYa : étude épidémiologique portant sur les modalités d'administration des thérapeutiques utilisées dans les IVG médicamenteuse en pratique courante dans les centres d'orthogénie ,
1 -Mécanismes d'action des médicaments In : Interruption volontaire de grossesse médicamenteuse ,
Antiprogestatifs : mécanisme d'action, Reprod Hum Horm, vol.12, issue.3, pp.248-53, 1999. ,
Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases, BJOG: An International Journal of Obstetrics and Gynaecology, vol.99, issue.2, 2002. ,
DOI : 10.1016/S0010-7824(00)00090-1
An effective regimen for early medical abortion: a report of 2000 consecutive cases, Human Reproduction, vol.13, issue.10, pp.2962-2967, 1998. ,
DOI : 10.1093/humrep/13.10.2962
Niveau de preuve et gradation des recommandations de bonne pratique. 2013 Avr, pp.1-92 ,
Interruption volontaire de grossesse m??dicamenteuse ?? domicile et ?? l???h??pital??: ??tude d???efficacit?? et d???acceptabilit??, Gyn??cologie Obst??trique & Fertilit??, vol.37, issue.11-12, pp.11-12, 2009. ,
DOI : 10.1016/j.gyobfe.2009.07.016
Results of a 4-year study on 15 447 medical abortions provided by privately practicing general practitioners and gynecologists in ,
Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation, Contraception, vol.86, issue.1, pp.67-73, 2012. ,
DOI : 10.1016/j.contraception.2011.11.010
Les femmes ayant recours à l'IVG : diversité des profils des femmes et des modalités de prise en charge, Revue Française des Affaires Sociales, vol.1, pp.117-165, 2011. ,
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review, Contraception, vol.87, issue.1, p.2013 ,
DOI : 10.1016/j.contraception.2012.06.011
Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period, Contraception, vol.72, issue.5 ,
DOI : 10.1016/j.contraception.2005.05.017
Tow distinct oral routes of misoprostol in mifepristone medical abortion : a randomized controlled trial, Obstet Gynecol, 2008. ,
A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion, Contraception, vol.86, issue.3 ,
DOI : 10.1016/j.contraception.2011.12.012
A radomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation. Contraception, pp.480-485, 2013. ,
Extending outpatient medical abortion services through 70 days of gestational age, Obstet Gynecol, vol.120, pp.1070-1076, 2012. ,
A systématique review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation ,
Are two doses of misoprostol after mifepristone for early abortion better than one ? BJOG, pp.271-279, 2007. ,
Medical methods for first trimester abortion, Cochrane Database Syst Rev, vol.11, p.2855, 2011. ,
DOI : 10.1002/14651858.cd002855.pub4
Early Pregnancy Termination with Mifepristone and Misoprostol in the United States, New England Journal of Medicine, vol.338, issue.18, pp.1241-1248, 1998. ,
DOI : 10.1056/NEJM199804303381801
Mifépristone and misoprostol sequential regimen side effects, complications and safety. Contraception, pp.48-55, 2006. ,
DOI : 10.1016/j.contraception.2006.03.016
Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting, Acta Obstetricia et Gynecologica Scandinavica, vol.7, issue.4 ,
DOI : 10.1016/S0010-7824(01)00266-9
Ultrasound Evaluation of the Endometrium After Medical Termination of Pregnancy, Obstetrics & Gynecology, vol.103, issue.5, Part 1, pp.871-876, 2004. ,
DOI : 10.1097/01.AOG.0000124782.69622.48
Verifying the effectiveness of medical abortion; ultrasound versus hCG testing, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.109, issue.2, pp.190-195, 2003. ,
DOI : 10.1016/S0301-2115(03)00012-5
Pain control in medical abortion, International Journal of Gynecology & Obstetrics, vol.36, issue.3, pp.275-80, 2001. ,
DOI : 10.1016/S0020-7292(01)00453-2
Timing of pain and bleeding after mifepristone-induced abortion, Contraception, vol.62, issue.6, pp.305-314, 2000. ,
DOI : 10.1016/S0010-7824(00)00181-5
Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity, Contraception, vol.83, issue.4 ,
DOI : 10.1016/j.contraception.2010.08.006
interruption volontaire de grossesse en ville: spécificités et difficultés rencontrées dans la pratique de ville dans le cadre de l'IVG par méthode médicamenteuse ,
Acceptability of home-use of misoprosotol in medical abortion. Contraception, pp.387-92, 2004. ,
Vaginal misoprostol administered at home after mifepristone (RU486) for abortion, J Fam Pract, vol.44, issue.4, pp.353-60, 1997. ,
DOI : 10.1001/jama.284.15.1948
Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review, Bulletin of the World Health Organization, vol.89, issue.5, pp.360-70, 2011. ,
DOI : 10.2471/BLT.10.084046
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days, Human Reproduction, vol.25, issue.5, pp.1153-57, 2010. ,
DOI : 10.1093/humrep/deq037
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial, Contraception, vol.89, issue.3, pp.181-187, 2014. ,
DOI : 10.1016/j.contraception.2013.10.018
URL : http://doi.org/10.1016/j.contraception.2013.10.018
Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment., BMJ, vol.307, issue.6906, pp.714-721, 1993. ,
DOI : 10.1136/bmj.307.6906.714
Medical versus surgical abortion: The importance of women's choice, Contraception, vol.82, issue.2, pp.224-233, 2011. ,
DOI : 10.1016/j.contraception.2010.04.107
WHO recommendations for misoprostol use for obstetric and gynecologic indications, International Journal of Gynecology & Obstetrics, vol.194, issue.(2), pp.186-195, 2013. ,
DOI : 10.1016/j.ijgo.2012.12.009
The combination of mifepristone and misoprostol for the termination of pregnancy, International Journal of Gynecology & Obstetrics, vol.99, issue.4, pp.1-4, 2011. ,
DOI : 10.1016/j.ijgo.2011.07.013
Misoprostol??: utilisation hors AMM au premier trimestre de la grossesse (fausses couches spontan??es, interruptions m??dicales et volontaires de grossesse), Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.2 ,
DOI : 10.1016/j.jgyn.2013.11.007
Misoprostol as a single agent for medical termination of pregnancy. (page consultée le 23 UpToDate ?, 2014. ,